DE69830910D1 - Kaliumkanal-proteine zur verwendung in gentherapie zur verminderung von erektiler dysfunktion - Google Patents

Kaliumkanal-proteine zur verwendung in gentherapie zur verminderung von erektiler dysfunktion

Info

Publication number
DE69830910D1
DE69830910D1 DE69830910T DE69830910T DE69830910D1 DE 69830910 D1 DE69830910 D1 DE 69830910D1 DE 69830910 T DE69830910 T DE 69830910T DE 69830910 T DE69830910 T DE 69830910T DE 69830910 D1 DE69830910 D1 DE 69830910D1
Authority
DE
Germany
Prior art keywords
smooth muscle
regulation
protein involved
present
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69830910T
Other languages
English (en)
Other versions
DE69830910T2 (de
Inventor
Jan Geliebter
Arnold Melman
J Christ
Jamil Rehman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albert Einstein College of Medicine
Original Assignee
Albert Einstein College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert Einstein College of Medicine filed Critical Albert Einstein College of Medicine
Publication of DE69830910D1 publication Critical patent/DE69830910D1/de
Application granted granted Critical
Publication of DE69830910T2 publication Critical patent/DE69830910T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11013—Protein kinase C (2.7.11.13)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69830910T 1997-02-13 1998-02-05 Kaliumkanal-proteine zur verwendung in gentherapie zur verminderung von erektiler dysfunktion Expired - Lifetime DE69830910T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US799144 1997-02-13
US08/799,144 US6150338A (en) 1997-02-13 1997-02-13 Gene therapy for alleviating erectile dysfunction
PCT/US1998/002249 WO1998036055A1 (en) 1997-02-13 1998-02-05 Gene therapy for alleviating erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69830910D1 true DE69830910D1 (de) 2005-08-25
DE69830910T2 DE69830910T2 (de) 2006-04-20

Family

ID=25175134

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69830910T Expired - Lifetime DE69830910T2 (de) 1997-02-13 1998-02-05 Kaliumkanal-proteine zur verwendung in gentherapie zur verminderung von erektiler dysfunktion

Country Status (12)

Country Link
US (1) US6150338A (de)
EP (1) EP1005538B1 (de)
JP (1) JP4158163B2 (de)
KR (1) KR100535782B1 (de)
AT (1) ATE299931T1 (de)
AU (1) AU745637B2 (de)
CA (1) CA2280770C (de)
DE (1) DE69830910T2 (de)
DK (1) DK1005538T3 (de)
ES (1) ES2246066T3 (de)
PT (1) PT1005538E (de)
WO (1) WO1998036055A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030096B1 (en) * 1997-02-13 2006-04-18 Albert Einstein College Of Medicine Of Yeshiva University Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein
US6271211B1 (en) 1997-02-13 2001-08-07 Albert Einstein College Of Medicine Of Yeshiva University Gene therapy for regulating penile smooth muscle tone
DK2075002T3 (da) * 1998-05-01 2013-05-21 Univ Pittsburgh Myoblaster til reparation af urinvejslukkemuskel
US6866842B1 (en) 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
US7115417B1 (en) 1998-05-01 2006-10-03 Chancellor Michael B Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
KR20010076961A (ko) * 2000-01-29 2001-08-17 김제종 성기능장애 예방 및 치료용 약제
CA2406393C (en) 2000-04-14 2012-10-02 University Of Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
JP4680483B2 (ja) 2001-02-23 2011-05-11 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組織および臓器の治療および修復に用いるための幹細胞マトリックスの迅速な調製方法
DE602004029349D1 (de) 2003-04-25 2010-11-11 Univ Pittsburgh Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und -regeneration
CN1621094A (zh) * 2003-11-26 2005-06-01 犹太大学阿尔伯特爱因斯坦医学院 用于调节平滑肌张力的基因转移
EP2118271B1 (de) 2007-01-11 2018-04-18 University of Pittsburgh - Of the Commonwealth System of Higher Education Zellen aus muskeln zur behandlung von harnwegserkrankungen sowie verfahren zu ihrer herstellung und verwendung
US20090042208A1 (en) * 2007-07-31 2009-02-12 Davies Kelvin P Assays for erectile and bladder dysfunction and vascular health
AU2009282619B2 (en) 2008-08-18 2015-08-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
CN102242973B (zh) * 2010-05-11 2013-10-09 爱烙达股份有限公司 热水器的储水桶
WO2020100089A2 (en) 2018-11-14 2020-05-22 Urovant Sciences Gmbh Compositions and methods for the treatment of smooth muscle dysfunction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0251244B1 (de) * 1986-06-27 1996-09-04 Takeda Chemical Industries, Ltd. Polypeptid und dessen Herstellung
US5324651A (en) * 1986-06-27 1994-06-28 Takeda Chemical Industries, Ltd. DNA encoding rat and human protein kinase C
DE3913954A1 (de) * 1989-04-27 1990-10-31 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA

Also Published As

Publication number Publication date
EP1005538B1 (de) 2005-07-20
ATE299931T1 (de) 2005-08-15
AU745637B2 (en) 2002-03-28
ES2246066T3 (es) 2006-02-01
JP4158163B2 (ja) 2008-10-01
KR20000071061A (ko) 2000-11-25
KR100535782B1 (ko) 2005-12-12
US6150338A (en) 2000-11-21
WO1998036055A1 (en) 1998-08-20
AU6146898A (en) 1998-09-08
JP2001517935A (ja) 2001-10-09
EP1005538A1 (de) 2000-06-07
DK1005538T3 (da) 2005-11-07
DE69830910T2 (de) 2006-04-20
CA2280770C (en) 2008-07-08
PT1005538E (pt) 2005-11-30
EP1005538A4 (de) 2002-12-04
CA2280770A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
DE69830910D1 (de) Kaliumkanal-proteine zur verwendung in gentherapie zur verminderung von erektiler dysfunktion
DE69230993D1 (de) Rekombinante viren vektoren zur expression in muskelzellen
EE04753B1 (et) Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarüootne rakk, meetod rekombinantse hTyr-proteiini valmistamiseks ning vaktsiin
HK1024714A1 (en) Dumbbell expression constructs for gene therapy
ZA891067B (en) Pox virus vectors
IL148021A0 (en) Novel b7-4 molecules and uses therefor
ATE329030T1 (de) Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert
DE69535703D1 (de) Aav-vermittelte überbringung von dna in zellen des nervensystems
ATE325533T1 (de) Verfahren zum verbesserten virusvermittelten dns- transfer unter verwendung von molekülen mit virus-und zellbindenden domänen
WO1998039426A3 (en) Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE59510829D1 (de) Gentherapeutisches verfahren unter verwendung von dna-vektoren ohne selektionsmarker-gen
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
RU2000122617A (ru) Самореплицирующийся рекомбинантный вектор, способ его получения, вакцина для иммунизации против вич с помощью днк, содержащая указанный вектор, способ лечения или профилактики вич и клетка-хозяин, содержащая указанный вектор
ES2107997T3 (es) Procedimiento de uso de vectores de expresion eucarioticos que comprenden el potenciador del virus bk.
DE60124910D1 (de) Menschliche twik-8 moleküle und ihre verwendung
DE59310334D1 (de) Vektor zur expression von therapeutisch relevanten genen
AU2002359572A8 (en) 15603, a human ion channel family member
MX9604240A (es) Transferencia mejorada de adn mediada por virus.
HUP9802960A2 (hu) Nukleinsav-konstrukciók génterápiához, amelyek aktivitását ciklinfüggő kinázok inhibitorai befolyásolják

Legal Events

Date Code Title Description
8364 No opposition during term of opposition